[
    {
        "cat": "Antidepressant",
        "subCat": "Atypical",
        "medName": "Mirtazapine (Remeron)",
        "indications": [
            {
                "indication": "MDD with comorbid ETOH (1st line monotherapy or 2nd line adjunct)",
                "modifier": 0
            },
            {
                "indication": "MDD - Elderly (1st line monotherapy)",
                "modifier": 0
            },
            {
                "indication": "Perimenopausal MDD (2nd line monotherapy)",
                "modifier": 0
            },
            {
                "indication": "Peripartum MDD (3rd line monotherapy)",
                "modifier": 0
            }
        ],
        "indicationsComment": "",
        "sideEffects": [
            {
                "sideEffect": "Sedation",
                "modifier": 0
            },
            {
                "sideEffect": "Appetite",
                "modifier": 0
            }
        ],
        "severeEffects": [
            {
                "severeEffect": "Serotonin syndrome",
                "modifier": 0
            },
            {
                "severeEffect": "Mania",
                "modifier": 0
            }
        ],
        "frequency": "",
        "doseInit": "15mg qhs",
        "doseInitComment": "",
        "doseRange": "15-45mg",
        "doseRangeComment": "",
        "maxDose": "45mg",
        "maxDoseForKids": "",
        "blackBoxWarning": "increased suicidality (<24yo with MDD)",
        "misc": "decreased sexual dysfunction, decreased drug interaction, 7.5mg most sedating",
        "miscComment": "",
        "equiv": "",
        "amphWorkUp": "",
        "mphWorkUp": ""
    }
]